45,160 In summary, most of the studied drugs did not show clinically significant DDIs related to delayed gastric emptying caused by GLP-1 RAs or a dual GLP-1/GIP RA administration
We work together with your diabetes care team to determine whether continuing, modifying, or changing your medication is the safest choice based on your specific situation
Semaglutide GLP-1 belongs to a category of medications known as GLP-1 receptor agonists, which mimic the glucagon-like peptide-1 hormone that regulates feelings of fullness after eating
Compounded GLP-1 helped curb my appetite, making daily routines feel much easier
Patients should be cautious about any claims of "generic tirzepatide" or compounded versions, as these products are not FDA-approved and may pose safety risks
About this article Cite this article Serrano-Arias, B., Araya-Ziga, A., Waterhouse-Garbanzo, J